Skip to main content

Advertisement

SpringerLink
Log in

Diagnosis and Management of Male Genital Lichen Sclerosus

  • Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Lichen sclerosus is a chronic inflammatory skin disease that has the potential to result in substantial patient morbidity and discomfort. If not identified and addressed early, lichen sclerosus has the tendency to progress to involve the anterior urethra and can result in significant and bothersome urethral stricture disease. Depending on the extent of urethral involvement and patient symptoms, management strategies range from simple topical ointments to major multi-stage urethral reconstructive operations. Herein, we describe the evaluation and management of male genital lichen sclerosus and provide a stepwise approach to treatment. However, although the treatment armamentarium for this difficult disease process continues to improve, our overall understanding of the pathogenesis of lichen sclerosus remains limited. Further research is required to better elucidate the underlying mechanisms and pathways involved to learn how we may be better able to control and prevent lichen sclerosus as a whole.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Stuhmer A. Balanitis xerotica obliterans (postoperationem) und ihre Beziehungen zur “Kraurosis glandis et praeputii penis”. Arch Derm Syphilol. 1928;156:613.

    Article  Google Scholar 

  2. Pugliese JM, Morey AF, Peterson AC. Lichen sclerosus: review of the literature and current recommendations for management. J Urol. 2007;178:2268.

    Article  PubMed  Google Scholar 

  3. Powell JJ, Wojnarowska F. Lichen sclerosus. Lancet. 1999;353:1777.

    Article  CAS  PubMed  Google Scholar 

  4. Erickson BA, Elliott SP, Myers JB, et al. Understanding the relationship between chronic systemic disease and lichen sclerosus urethral strictures. J Urol. 2016;195:363.

    Article  PubMed  Google Scholar 

  5. Kizer WS, Prarie T, Morey AF. Balanitis xerotica obliterans: epidemiologic distribution in an equal access health care system. South Med J. 2003;96:9.

    Article  PubMed  Google Scholar 

  6. Yesudian PD, Sugunendran H, Bates CM, et al. Lichen sclerosus. Int J STD AIDS. 2005;16:465.

    Article  CAS  PubMed  Google Scholar 

  7. Nelson DM, Peterson AC. Lichen sclerosus: epidemiological distribution in an equal access health care system. J Urol. 2011;185:522.

    Article  PubMed  Google Scholar 

  8. Das S, Tunuguntla HS. Balanitis xerotica obliterans—a review. World J Urol. 2000;18:382.

    Article  CAS  PubMed  Google Scholar 

  9. Kiss A, Kiraly L, Kutasy B, et al. High incidence of balanitis xerotica obliterans in boys with phimosis: prospective 10-year study. Pediatr Dermatol. 2005;22:305.

    Article  PubMed  Google Scholar 

  10. Yardley IE, Cosgrove C, Lambert AW. Paediatric preputial pathology: are we circumcising enough? Ann R Coll Surg Engl. 2007;89:62.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Jayakumar S, Antao B, Bevington O, et al. Balanitis xerotica obliterans in children and its incidence under the age of 5 years. J Pediatr Urol. 2012;8:272.

    Article  CAS  PubMed  Google Scholar 

  12. Miller RA. The Koebner phenomenon. Int J Dermatol. 1982;21:192.

    Article  CAS  PubMed  Google Scholar 

  13. Pock L. Koebner phenomenon in lichen sclerosus et atrophicus. Dermatologica. 1990;181:76.

    Article  CAS  PubMed  Google Scholar 

  14. Milligan A, Graham-Brown RA, Burns DA. Lichen sclerosus et atrophicus following sunburn. Clin Exp Dermatol. 1988;13:36.

    Article  CAS  PubMed  Google Scholar 

  15. Yates VM, King CM, Dave VK. Lichen sclerosus et atrophicus following radiation therapy. Arch Dermatol. 1985;121:1044.

    Article  CAS  PubMed  Google Scholar 

  16. Pass CJ. An unusual variant of lichen sclerosus et atrophicus: delayed appearance in a surgical scar. Cutis. 1984;33:405.

    CAS  PubMed  Google Scholar 

  17. Regauer S. Immune dysregulation in lichen sclerosus. Eur J Cell Biol. 2005;84:273.

    Article  CAS  PubMed  Google Scholar 

  18. Meyrick Thomas RH, Ridley CM, Black MM. The association of lichen sclerosus et atrophicus and autoimmune-related disease in males. Br J Dermatol. 1983;109:661.

    Article  CAS  PubMed  Google Scholar 

  19. Cooper SM, Ali I, Baldo M, et al. The association of lichen sclerosus and erosive lichen planus of the vulva with autoimmune disease: a case–control study. Arch Dermatol. 2008;144:1432.

    PubMed  Google Scholar 

  20. Edmonds EV, Oyama N, Chan I, et al. Extracellular matrix protein 1 autoantibodies in male genital lichen sclerosus. Br J Dermatol. 2011;165:218.

    Article  CAS  PubMed  Google Scholar 

  21. Azurdia RM, Luzzi GA, Byren I, et al. Lichen sclerosus in adult men: a study of HLA associations and susceptibility to autoimmune disease. Br J Dermatol. 1999;140:79.

    Article  CAS  PubMed  Google Scholar 

  22. Lipscombe TK, Wayte J, Wojnarowska F, et al. A study of clinical and aetiological factors and possible associations of lichen sclerosus in males. Australas J Dermatol. 1997;38:132.

    Article  CAS  PubMed  Google Scholar 

  23. Kreuter A, Kryvosheyeva Y, Terras S, et al. Association of autoimmune diseases with lichen sclerosus in 532 male and female patients. Acta Derm Venereol. 2013;93:238.

    Article  PubMed  Google Scholar 

  24. Schempp C, Bocklage H, Lange R, et al. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol. 1993;100:717.

    Article  CAS  PubMed  Google Scholar 

  25. Weide B, Schittek B, Klyscz T, et al. Morphoea is neither associated with features of Borrelia burgdorferi infection, nor is this agent detectable in lesional skin by polymerase chain reaction. Br J Dermatol. 2000;143:780.

    Article  CAS  PubMed  Google Scholar 

  26. Weide B, Walz T, Garbe C. Is morphoea caused by Borrelia burgdorferi? A review. Br J Dermatol. 2000;142:636.

    Article  CAS  PubMed  Google Scholar 

  27. Drut RM, Gomez MA, Drut R, et al. Human papillomavirus is present in some cases of childhood penile lichen sclerosus: an in situ hybridization and SP-PCR study. Pediatr Dermatol. 1998;15:85.

    Article  CAS  PubMed  Google Scholar 

  28. Gunthert AR, Faber M, Knappe G, et al. Early onset vulvar lichen sclerosus in premenopausal women and oral contraceptives. Eur J Obstet Gynecol Reprod Biol. 2008;137:56.

    Article  PubMed  Google Scholar 

  29. Meyrick Thomas RH, Ridley CM, McGibbon DH, et al. Lichen sclerosus et atrophicus and autoimmunity—a study of 350 women. Br J Dermatol. 1988;118:41.

    Article  CAS  PubMed  Google Scholar 

  30. Kohlberger PD, Joura EA, Bancher D, et al. Evidence of androgen receptor expression in lichen sclerosus: an immunohistochemical study. J Soc Gynecol Investig. 1998;5:331.

    Article  CAS  PubMed  Google Scholar 

  31. Depasquale I, Park AJ, Bracka A. The treatment of balanitis xerotica obliterans. BJU Int. 2000;86:459. This manuscript provides a comprehensive review of male genital lichen sclerosus, providing historical data and the authors’ experience with more than 500 patients over a 14-year period.

    Article  CAS  PubMed  Google Scholar 

  32. Gargollo PC, Kozakewich HP, Bauer SB, et al. Balanitis xerotica obliterans in boys. J Urol. 2005;174:1409.

    Article  PubMed  Google Scholar 

  33. Garaffa G, Shabbir M, Christopher N, et al. The surgical management of lichen sclerosus of the glans penis: our experience and review of the literature. J Sex Med. 2011;8:1246.

    Article  PubMed  Google Scholar 

  34. Venn SN, Mundy AR. Urethroplasty for balanitis xerotica obliterans. Br J Urol. 1998;81:735.

    Article  CAS  PubMed  Google Scholar 

  35. Edmonds EV, Hunt S, Hawkins D, et al. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol. 2012;26:730.

    Article  CAS  PubMed  Google Scholar 

  36. Peterson AC, Palminteri E, Lazzeri M, et al. Heroic measures may not always be justified in extensive urethral stricture due to lichen sclerosus (balanitis xerotica obliterans). Urology. 2004;64:565. Peterson et al. evaluated patients with extensive urethral stricture disease secondary to LS and found that, for a significant number of patients, a perineal urethrostomy should be considered a viable option. The authors do state that for young men who desire standing penile voiding, definitive urethroplasty should be considered.

    Article  PubMed  Google Scholar 

  37. Liu JS, Walker K, Stein D, et al. Lichen sclerosus and isolated bulbar urethral stricture disease. J Urol. 2014;192:775.

    Article  PubMed  Google Scholar 

  38. Powell J, Robson A, Cranston D, et al. High incidence of lichen sclerosus in patients with squamous cell carcinoma of the penis. Br J Dermatol. 2001;145:85.

    Article  CAS  PubMed  Google Scholar 

  39. Barbagli G, Palminteri E, Mirri F, et al. Penile carcinoma in patients with genital lichen sclerosus: a multicenter survey. J Urol. 2006;175:1359.

    Article  CAS  PubMed  Google Scholar 

  40. Nasca MR, Innocenzi D, Micali G. Penile cancer among patients with genital lichen sclerosus. J Am Acad Dermatol. 1999;41:911.

    Article  CAS  PubMed  Google Scholar 

  41. Velazquez EF, Cubilla AL. Lichen sclerosus in 68 patients with squamous cell carcinoma of the penis: frequent atypias and correlation with special carcinoma variants suggests a precancerous role. Am J Surg Pathol. 2003;27:1448.

    Article  PubMed  Google Scholar 

  42. Pietrzak P, Hadway P, Corbishley CM, et al. Is the association between balanitis xerotica obliterans and penile carcinoma underestimated? BJU Int. 2006;98:74.

    Article  PubMed  Google Scholar 

  43. von Krogh, G., Horenblas, S.: The management and prevention of premalignant penile lesions. Scand J Urol Nephrol Suppl: 220, 2000

  44. Weber P, Rabinovitz H, Garland L. Verrucous carcinoma in penile lichen sclerosus et atrophicus. J Dermatol Surg Oncol. 1987;13:529.

    Article  CAS  PubMed  Google Scholar 

  45. Clouston D, Hall A, Lawrentschuk N. Penile lichen sclerosus (balanitis xerotica obliterans). BJU Int. 2011;108 Suppl 2:14.

    Article  PubMed  Google Scholar 

  46. Val I, Almeida G. An overview of lichen sclerosus. Clin Obstet Gynecol. 2005;48:808.

    Article  PubMed  Google Scholar 

  47. Kiss A, Csontai A, Pirot L, et al. The response of balanitis xerotica obliterans to local steroid application compared with placebo in children. J Urol. 2001;165:219.

    Article  CAS  PubMed  Google Scholar 

  48. Vincent MV, Mackinnon E. The response of clinical balanitis xerotica obliterans to the application of topical steroid-based creams. J Pediatr Surg. 2005;40:709.

    Article  PubMed  Google Scholar 

  49. Bracco GL, Carli P, Sonni L, et al. Clinical and histologic effects of topical treatments of vulval lichen sclerosus. A critical evaluation. J Reprod Med. 1993;38:37.

    CAS  PubMed  Google Scholar 

  50. Stewart L, McCammon K, Metro M, et al. SIU/ICUD Consultation on Urethral Strictures: anterior urethra-lichen sclerosus. Urology. 2014;83:S27.

    Article  PubMed  Google Scholar 

  51. Dalziel, K. L., Millard, P. R., Wojnarowska, F.: The treatment of vulval lichen sclerosus with a very potent topical steroid (clobetasol propionate 0.05%) cream. Br J Dermatol, 124: 461, 1991

  52. Fischer G, Rogers M. Treatment of childhood vulvar lichen sclerosus with potent topical corticosteroid. Pediatr Dermatol. 1997;14:235.

    Article  CAS  PubMed  Google Scholar 

  53. Pandher BS, Rustin MH, Kaisary AV. Treatment of balanitis xerotica obliterans with topical tacrolimus. J Urol. 2003;170:923.

    Article  CAS  PubMed  Google Scholar 

  54. Funaro D, Lovett A, Leroux N, et al. A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus. J Am Acad Dermatol. 2014;71:84.

    Article  CAS  PubMed  Google Scholar 

  55. Anderson K, Ascanio NM, Kinney MA, et al. A retrospective analysis of pediatric patients with lichen sclerosus treated with a standard protocol of class I topical corticosteroid and topical calcineurin inhibitor. J Dermatolog Treat. 2016;27:64.

    Article  CAS  PubMed  Google Scholar 

  56. Kyriakou A, Patsialas C, Patsatsi A, et al. Treatment of male genital lichen sclerosus with clobetasol propionate and maintenance with either methylprednisolone aceponate or tacrolimus: a retrospective study. J Dermatolog Treat. 2013;24:431.

    Article  CAS  PubMed  Google Scholar 

  57. Ebert AK, Rosch WH, Vogt T. Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study. Eur Urol. 2008;54:932.

    Article  CAS  PubMed  Google Scholar 

  58. Feig JL, Gribetz ME, Lebwohl MG. Chronic lichen sclerosus successfully treated with intralesional adalimumab. Br J Dermatol. 2016;174:687.

    Article  CAS  PubMed  Google Scholar 

  59. Lowenstein EB, Zeichner JA. Intralesional adalimumab for the treatment of refractory balanitis xerotica obliterans. JAMA Dermatol. 2013;149:23.

    Article  PubMed  Google Scholar 

  60. Mazdisnian F, Degregorio F, Mazdisnian F, et al. Intralesional injection of triamcinolone in the treatment of lichen sclerosus. J Reprod Med. 1999;44:332.

    CAS  PubMed  Google Scholar 

  61. Zucchi, A., Cai, T., Cavallini, G. et al.: Genital lichen sclerosus in male patients: a new treatment with polydeoxyribonucleotide. Urol Int, 2016

  62. Pasieczny TA. The treatment of balanitis xerotica obliterans with testosterone propionate ointment. Acta Derm Venereol. 1977;57:275.

    CAS  PubMed  Google Scholar 

  63. Ayhan A, Guven S, Guvendag Guven ES, et al. Topical testosterone versus clobetasol for vulvar lichen sclerosus. Int J Gynaecol Obstet. 2007;96:117.

    Article  CAS  PubMed  Google Scholar 

  64. Olejek A, Kozak-Darmas I, Kellas-Sleczka S, et al. Effectiveness of photodynamic therapy in the treatment of lichen sclerosus: cell changes in immunohistochemistry. Neuro Endocrinol Lett. 2009;30:547.

    PubMed  Google Scholar 

  65. Rosemberg SK, Jacobs H. Continuous wave carbon dioxide treatment of balanitis xerotica obliterans. Urology. 1982;19:539.

    Article  CAS  PubMed  Google Scholar 

  66. Aynaud O, Plantier F. Genital lichen sclerosus treated by carbon dioxide laser. Eur J Dermatol. 2010;20:387.

    PubMed  Google Scholar 

  67. Mehraban S, Feily A. 308nm excimer laser in dermatology. J Lasers Med Sci. 2014;5:8.

    PubMed  PubMed Central  Google Scholar 

  68. Blaschko SD GT, Alwaal Q, Harris CR, McCulloch CE, McAninch JW, Breyer BN. Lichen sclerosus comorbidities and complications from a national sample of patients treated with urethroplasty. Urology Practice. 2015;2:329.

    Article  Google Scholar 

  69. Wessells H, A. K., Elliott SP, Gonzales CM, Kodama RT, Peterson AC, Resont J, Rourke K, Stoffel JT, Vanni A, Voelzke B, Zhao L, Santucci RA: Male urethral stricture: AUA Guideline. Approved by AUA Board of Directors April 2016, 2016. The recently released AUA guidelines on urethral stricture disease specifically address patients with strictures secondary to LS and recommend against the use of genital skin in reconstruction. These represent the first guidelines from the AUA addressing this patient population.

  70. Tausch TJ, Peterson AC. Early aggressive treatment of lichen sclerosus may prevent disease progression. J Urol. 2012;187:2101.

    Article  PubMed  Google Scholar 

  71. Morey AF, Lin HC, DeRosa CA, et al. Fossa navicularis reconstruction: impact of stricture length on outcomes and assessment of extended meatotomy (first stage Johanson) maneuver. J Urol. 2007;177:184.

    Article  PubMed  Google Scholar 

  72. Potts, B. A., Belsante, M. J., Peterson, A. C.: Intraurethral steroids are a safe and effective treatment for stricture disease in patients with biopsy proven lichen sclerosus. J Urol, 2015

  73. Virasoro R, Eltahawy EA, Jordan GH. Long-term follow-up for reconstruction of strictures of the fossa navicularis with a single technique. BJU Int. 2007;100:1143.

    PubMed  Google Scholar 

  74. Kulkarni S, Barbagli G, Kirpekar D, et al. Lichen sclerosus of the male genitalia and urethra: surgical options and results in a multicenter international experience with 215 patients. Eur Urol. 2009;55:945.

    Article  PubMed  Google Scholar 

  75. Xu YM, Feng C, Sa YL, et al. Outcome of 1-stage urethroplasty using oral mucosal grafts for the treatment of urethral strictures associated with genital lichen sclerosus. Urology. 2014;83:232.

    Article  PubMed  Google Scholar 

  76. Levine LA, Strom KH, Lux MM. Buccal mucosa graft urethroplasty for anterior urethral stricture repair: evaluation of the impact of stricture location and lichen sclerosus on surgical outcome. J Urol. 2007;178:2011.

    Article  PubMed  Google Scholar 

  77. Patel CK, Buckley JC, Zinman LN, et al. Outcomes for management of lichen sclerosus urethral strictures by 3 different techniques. Urology. 2016;91:215. Patel et al. retrospectively reviewed their experience in treatment of men with significant urethral stricture disease due to LS. This series is the most contemporary report of reconstructive options and highlights the significant difficulties in managing this difficult patient population.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urologic Surgery, A 1302 Medical Center North, Vanderbilt University Medical Center, Nashville, TN, 37232, USA

    Niels V. Johnsen, Elizabeth T. Brown, W. Stuart Reynolds, Melissa R. Kaufman, Douglas F. Milam & Roger R. Dmochowski

Authors
  1. Niels V. Johnsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth T. Brown
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Stuart Reynolds
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Melissa R. Kaufman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Douglas F. Milam
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Roger R. Dmochowski
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Niels V. Johnsen.

Ethics declarations

Conflict of Interests

Drs Johnsen, Brown, Reynolds, Kaufman, Milam, and Dmochowski declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain studies with human or animal subjects performed by the author.

Additional information

This article is part of the Topical Collection on Inflammatory/Infectious Bladder Disorders

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Johnsen, N.V., Brown, E.T., Reynolds, W.S. et al. Diagnosis and Management of Male Genital Lichen Sclerosus. Curr Bladder Dysfunct Rep 11, 234–241 (2016). https://doi.org/10.1007/s11884-016-0375-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-016-0375-2

Keywords

Search

Navigation